Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Return on Assets (2016 - 2025)

Sunshine Biopharma's Return on Assets history spans 12 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Assets changed 0.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, changed 0.0%, while the annual FY2025 figure was 0.04%, 1.0% down from the prior year.
  • Return on Assets reached 0.04% in Q4 2025 per SBFM's latest filing, up from 0.02% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.05% in Q1 2025 to a low of 6.07% in Q3 2021.
  • Average Return on Assets over 5 years is 1.29%, with a median of 0.17% recorded in 2022.
  • Peak YoY movement for Return on Assets: crashed -491bps in 2021, then surged 601bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 5.29% in 2021, then surged by 86bps to 0.76% in 2022, then skyrocketed by 79bps to 0.16% in 2023, then skyrocketed by 127bps to 0.04% in 2024, then decreased by -11bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Return on Assets are 0.04% (Q4 2025), 0.02% (Q3 2025), and 0.01% (Q2 2025).